お知らせ • Jun 30
Nevis Brands Inc., Annual General Meeting, Aug 27, 2025 Nevis Brands Inc., Annual General Meeting, Aug 27, 2025. Location: british columbia, vancouver Canada お知らせ • Feb 21
Nevis Brands Inc. announced that it expects to receive $0.1 million in funding Nevis Brands Inc. announced that it will issue an unsecured promissory note with returning investor, John Kueber for principal amount of $100,000 on February 20, 2025. The Kueber Note carry a coupon of 10% per annum and will mature on February 15, 2026. The transaction has been approved by the shareholder board. お知らせ • Oct 27
Nevis Brands Inc. announced that it expects to receive $0.225 million in funding Nevis Brands Inc. announced a non-brokered private placement of up to 2,500,000 common shares at a price of $0.09 per share for aggregate gross proceeds of up to $225,000 on October 25, 2024. The transaction will include participation from certain insiders of the company. All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance. お知らせ • Jul 04
Nevis Brands Inc., Annual General Meeting, Aug 29, 2024 Nevis Brands Inc., Annual General Meeting, Aug 29, 2024. Location: british columbia, vancouver Canada お知らせ • May 10
Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington State Nevis Brands Inc. announced it has received necessary state regulatory approvals and is completing production on 3 new products to add to its existing portfolio of products for sale in Washington State. These include Major(TM) Apple Peach 100mg Shots Major(TM) Zero Cal Lemonade 100mg Shots Happy Apple (TM) 10mg Cans. These new products will be in market in May 2024 and are expected to contribute to the company's royalty revenues beginning June 2024. Washington State dispensaries currently sell over $700,000 per month of Nevis related products through licensed dispensaries. Products include Major(TM) in 9 flavors, Happy Apple(TM) 100mg bottles, Vertus(TM) a sparkling cider designed to emulate Prosecco, and Velvet Swing(TM). Nevis collects royalties on the sale of these products through its exclusive licensee in each market. The Company may also introduce these new products to licensees in other states. Nevis Brands products are currently sold in Washington, Oregon, Arizona, Ohio, Colorado, California, Missouri and Nevada. The Company is preparing for production in Michigan. お知らせ • Dec 19
Nevis Brands Inc. Announces Product Extension in Ohio Nevis Brands Inc. announced several corporate updates: Product Extension in Ohio: The Company has expanded its Major line of beverages to include a 6th flavor of Major: Atomic Apple. Production has now been completed and inventory is being sold to Ohio retailers. Product Expansion: Washington State. The Company has filed 3 new products for approval in Washington State. The products include two new beverage products and an additional edible product. Nevis will announce specifics of the products upon approval and when production has started. お知らせ • Jul 07
Nevis Brands Inc. announced that it has received CAD 2 million in funding On July 6, 2023, Nevis Brands Inc. closed the transaction. The company issued 4,805,000 common shares at an issue price of CAD 0.10 per share for gross proceeds of CAD 480,500 in its second and final tranche closing. The company issued 2,402,500 share purchase warrants exercisable for one year at a price of CAD 0.20 per share. A finder’s fee of CAD 32,235 was paid and the finder was issued 230,250 warrants on the same terms as the private placement warrants. All shares have a hold period expiring November 7, 2023. お知らせ • Jun 17
Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023 Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023. Location: Vancouver, BC Vancouver Canada お知らせ • May 19
Pascal Biosciences Inc.'s Shares Will Be De-Listed from the TSX.V At the Close of the Market on May 23, 2023 Shareholders of Pascal Biosciences Inc. owning 56% of the issued shares of the company have approved the reorganization of the company, including delisting from the TSX Venture Exchange. Details of the reorganization were disclosed in prior releases dated Dec. 9, 2022, and Feb. 15, 2023. At the request of the Company, the Shares will be de-listed from the TSX.V at the close of the market on May 23, 2023. Immediately thereafter: (i) the Company's name will be changed to Nevis Brands Inc., (ii) the Shares will consolidate on the basis of one new share for five old shares, and (iii) the Company's board of directors and the CEO will change. A news release will be issued the next day providing details about the new directors and the CEO. The Company has received a conditional listing letter dated April 26, 2023 from the Canadian Securities Exchange (the "CSE"). That letter requires the Company's reorganization to complete on the day the Shares are listed on the CSE (the "Listing Date"). On the Listing Date, a private placement of $2,000,000 (the "Private Placement") and the acquisition of THC Essentials (the Acquisition") are required to close as well as issuing Shares for debt, which will complete the reorganization. Completion of the transactions disclosed in this press release are subject to a number of conditions, including closing the Private Placement and the Acquisition. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in further news releases or the CSE form 2AListing Statement, still to be finalized, any information released or received with respect to the transactions may not be accurate or complete and should not be relied upon. The Shares of the Company have been halted since the first week of December 2022.